Terms ending in 2031
Every in-force patent on Abbott Laboratories's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,266,950 | Isolation and Purification of Anti-IL-13 Antibodies Using Protein A Affinity Chromatography In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,426,408 | Pyrimidine Inhibitors of Kinases In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,962,629 | Novel Tricyclic Compounds In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,546,405 | Anti-Viral Compounds In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | |
| US 8,631,953 | Closure for container for holding biological samples In force · High confidence | Abbott Molecular Inc. | In force | High confidence | |
| US 8,143,284 | Poly(ADP-RIBOSE)polymerase Inhibitors In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D778,152 | Receptacle In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 8,398,966 | IL-1 Binding Proteins In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,627,981 | Container In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 8,679,128 | Apparatus and Methods for Reduction of Vertebral Bodies in a Spine In force · High confidence | Highridge Medical, LLC | In force | High confidence | |
| 91 more term ends in 2031 · Pro | |||||
10 of 101 patents shown. Soonest term end first, then patent number.
Pro members see all 101.
47 of these are in force and held by Abbott Laboratories.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.